Additional information
| Weight | 0.94 oz |
|---|---|
| Strength | 5mg, 10mg |
Price range: $46.75 through $67.15 SAVE 15%
-15%Synthetic thymosin beta-4 acetate research peptide studied in actin regulation, cellular migration, angiogenesis, and tissue remodeling. For research use only — not for human consumption.
This product is from our second production run. Samples from Batch 2 are currently with Janoshik Analytical for independent testing. Results will be posted here as they become available.
Due to recent supply chain and international shipping disruptions, some Batch 002 inventory may include vials produced at different points within our supplier’s production cycle. As a result, researchers may notice minor packaging variations, including differences in vial caps.
These products were sourced from the same established manufacturers we have worked with for ongoing quality and third-party testing. That said, we want to be transparent that Batch 002 may not represent a single uninterrupted production run.
We are already working with our suppliers to strengthen batch-control, packaging, and documentation protocols before Batch 003.
TB-500 is commonly used as a catalog name in the research peptide market. This product is identified as full-length thymosin β4 acetate — a 43-amino-acid peptide with molecular weight 4963.44 Da — rather than a separately identified shorter TB-500 fragment.
Batch COA/testing documentation is used to verify the material identity.
| Weight | 0.94 oz |
|---|---|
| Strength | 5mg, 10mg |
Due to recent supply chain and international shipping disruptions, some Batch 002 inventory may include vials produced at different points within our supplier’s production cycle. As a result, researchers may notice minor packaging variations, including differences in vial caps.
These products were sourced from the same established manufacturers we have worked with for ongoing quality and third-party testing. That said, we want to be transparent that Batch 002 may not represent a single uninterrupted production run.
We are already working with our suppliers to strengthen batch-control, packaging, and documentation protocols before Batch 003.